HOOKIPA PHARMA INC's ticker is HOOK and the CUSIP is 43906K100. A total of 58 filers reported holding HOOKIPA PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $436 | -30.0% | 708 | 0.0% | 0.00% | – |
| Q2 2023 | $623 | -58.9% | 708 | -65.6% | 0.00% | – |
| Q1 2023 | $1,516 | -30.6% | 2,060 | -23.7% | 0.00% | – |
| Q4 2022 | $2,186 | -56.3% | 2,699 | -20.2% | 0.00% | – |
| Q3 2022 | $5,000 | +25.0% | 3,383 | +32.6% | 0.00% | – |
| Q2 2022 | $4,000 | -50.0% | 2,552 | -25.7% | 0.00% | – |
| Q1 2022 | $8,000 | -98.2% | 3,433 | -98.2% | 0.00% | -100.0% |
| Q4 2021 | $455,000 | -56.3% | 195,363 | +10.5% | 0.00% | -50.0% |
| Q3 2021 | $1,041,000 | -54.4% | 176,769 | -29.0% | 0.00% | -50.0% |
| Q2 2021 | $2,281,000 | +448.3% | 248,983 | +704.1% | 0.00% | +300.0% |
| Q1 2021 | $416,000 | +13766.7% | 30,964 | +8201.3% | 0.00% | – |
| Q1 2020 | $3,000 | – | 373 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,842,902 | $17,452,000 | 0.32% |
| Samsara BioCapital, LLC | 116,602 | $1,104,000 | 0.31% |
| Artal Group S.A. | 599,616 | $5,678,000 | 0.14% |
| HHLR ADVISORS, LTD. | 943,254 | $8,933,000 | 0.07% |
| DAFNA Capital Management LLC | 22,061 | $209,000 | 0.07% |
| Baker Brothers Advisors | 700,481 | $6,634,000 | 0.03% |
| ZACKS INVESTMENT MANAGEMENT | 72,064 | $682,000 | 0.01% |
| HOWLAND CAPITAL MANAGEMENT LLC | 14,728 | $139,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 14,374 | $139,000 | 0.00% |
| Squarepoint Ops LLC | 12,699 | $120,000 | 0.00% |